These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 26215385)

  • 21. Effect of hormone therapy on mortality rates among women with heart failure and coronary artery disease.
    Bibbins-Domingo K; Lin F; Vittinghoff E; Barrett-Connor E; Hulley SB; Grady D; Shlipak MG
    Am J Cardiol; 2005 Jan; 95(2):289-91. PubMed ID: 15642574
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-risk percutaneous coronary intervention with the TandemHeart and Impella devices: a single-center experience.
    Schwartz BG; Ludeman DJ; Mayeda GS; Kloner RA; Economides C; Burstein S
    J Invasive Cardiol; 2011 Oct; 23(10):417-24. PubMed ID: 21972160
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An angiotensin receptor blocker reduces the risk of congestive heart failure in elderly hypertensive patients with renal insufficiency.
    Nakamura T; Kanno Y; Takenaka T; Suzuki H;
    Hypertens Res; 2005 May; 28(5):415-23. PubMed ID: 16156505
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aldosterone, mortality, and acute ischaemic events in coronary artery disease patients outside the setting of acute myocardial infarction or heart failure.
    Ivanes F; Susen S; Mouquet F; Pigny P; Cuilleret F; Sautière K; Collet JP; Beygui F; Hennache B; Ennezat PV; Juthier F; Richard F; Dallongeville J; Hillaert MA; Doevendans PA; Jude B; Bertrand M; Montalescot G; Van Belle E
    Eur Heart J; 2012 Jan; 33(2):191-202. PubMed ID: 21719456
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute coronary syndrome and khat herbal amphetamine use: an observational report.
    Ali WM; Al Habib KF; Al-Motarreb A; Singh R; Hersi A; Al Faleh H; Asaad N; Al Saif S; Almahmeed W; Sulaiman K; Amin H; Al-Lawati J; Al Bustani N; Al-Sagheer NQ; Al-Qahtani A; Al Suwaidi J
    Circulation; 2011 Dec; 124(24):2681-9. PubMed ID: 22155995
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sex differences in lifetime risk and first manifestation of cardiovascular disease: prospective population based cohort study.
    Leening MJ; Ferket BS; Steyerberg EW; Kavousi M; Deckers JW; Nieboer D; Heeringa J; Portegies ML; Hofman A; Ikram MA; Hunink MG; Franco OH; Stricker BH; Witteman JC; Roos-Hesselink JW
    BMJ; 2014 Nov; 349():g5992. PubMed ID: 25403476
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Angiotensin II receptor blocker-based vs. non-angiotensin II receptor blocker-based therapy in patients with angiographically documented coronary artery disease and hypertension: the Heart Institute of Japan Candesartan Randomized Trial for Evaluation in Coronary Artery Disease (HIJ-CREATE).
    Kasanuki H; Hagiwara N; Hosoda S; Sumiyoshi T; Honda T; Haze K; Nagashima M; Yamaguchi J; Origasa H; Urashima M; Ogawa H;
    Eur Heart J; 2009 May; 30(10):1203-12. PubMed ID: 19346521
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictors of long-term clinical endpoints in patients with refractory angina.
    Povsic TJ; Broderick S; Anstrom KJ; Shaw LK; Ohman EM; Eisenstein EL; Smith PK; Alexander JH
    J Am Heart Assoc; 2015 Jan; 4(2):. PubMed ID: 25637344
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcomes among 3.5 million newly diagnosed hypertensive Canadians.
    Quan H; Chen G; Tu K; Bartlett G; Butt DA; Campbell NR; Hemmelgarn BR; Hill MD; Johansen H; Khan N; Lix LM; Smith M; Svenson L; Walker RL; Wielgosz A; McAlister FA;
    Can J Cardiol; 2013 May; 29(5):592-7. PubMed ID: 23465341
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of stroke occurring in the SYNTAX trial comparing coronary artery bypass surgery and percutaneous coronary intervention in the treatment of complex coronary artery disease.
    Mack MJ; Head SJ; Holmes DR; Ståhle E; Feldman TE; Colombo A; Morice MC; Unger F; Erglis A; Stoler R; Dawkins KD; Serruys PW; Mohr FW; Kappetein AP
    JACC Cardiovasc Interv; 2013 Apr; 6(4):344-54. PubMed ID: 23523456
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of visit-to-visit variability and systolic blood pressure control on subsequent outcomes in hypertensive patients with coronary artery disease (from the HIJ-CREATE substudy).
    Arashi H; Ogawa H; Yamaguchi J; Kawada-Watanabe E; Hagiwara N
    Am J Cardiol; 2015 Jul; 116(2):236-42. PubMed ID: 25966826
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Growth differentiation factor 15 and cardiovascular events in patients with stable ischemic heart disease (The Heart and Soul Study).
    Schopfer DW; Ku IA; Regan M; Whooley MA
    Am Heart J; 2014 Feb; 167(2):186-192.e1. PubMed ID: 24439979
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparisons of ambulatory blood pressure monitoring and repeated office measurements in primary care.
    Pearce KA; Evans GW; Summerson J; Rao JS
    J Fam Pract; 1997 Nov; 45(5):426-33. PubMed ID: 9374969
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is systolic blood pressure below 150 mm Hg an appropriate goal for primary prevention of cardiovascular events among elderly population?
    Mohebi R; Mohebi A; Ghanbarian A; Momenan A; Azizi F; Hadaegh F
    J Am Soc Hypertens; 2014 Jul; 8(7):491-7. PubMed ID: 25064771
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term prognostic implications of visit-to-visit blood pressure variability in patients with ischemic stroke.
    Lau KK; Wong YK; Teo KC; Chang RS; Chan KH; Hon SF; Wat KL; Cheung RT; Li LS; Siu CW; Tse HF
    Am J Hypertens; 2014 Dec; 27(12):1486-94. PubMed ID: 24842389
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased risk of stroke in patients with coronary artery disease and sleep apnea: a 10-year follow-up.
    Valham F; Mooe T; Rabben T; Stenlund H; Wiklund U; Franklin KA
    Circulation; 2008 Aug; 118(9):955-60. PubMed ID: 18697817
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NSAID use and association with cardiovascular outcomes in outpatients with stable atherothrombotic disease.
    Kohli P; Steg PG; Cannon CP; Smith SC; Eagle KA; Ohman EM; Alberts MJ; Hoffman E; Guo J; Simon T; Sorbets E; Goto S; Bhatt DL;
    Am J Med; 2014 Jan; 127(1):53-60.e1. PubMed ID: 24280110
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prior polyvascular disease: risk factor for adverse ischaemic outcomes in acute coronary syndromes.
    Bhatt DL; Peterson ED; Harrington RA; Ou FS; Cannon CP; Gibson CM; Kleiman NS; Brindis RG; Peacock WF; Brener SJ; Menon V; Smith SC; Pollack CV; Gibler WB; Ohman EM; Roe MT;
    Eur Heart J; 2009 May; 30(10):1195-202. PubMed ID: 19339264
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coronary artery bypass: predictors of 30-day operative mortality in Jordanians.
    AlWaqfi N; Khader Y; Ibrahim K
    Asian Cardiovasc Thorac Ann; 2012 Jun; 20(3):245-51. PubMed ID: 22718710
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stroke and coronary heart disease in treated hypertension -- a prospective cohort study over three decades.
    Almgren T; Persson B; Wilhelmsen L; Rosengren A; Andersson OK
    J Intern Med; 2005 Jun; 257(6):496-502. PubMed ID: 15910553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.